AI in medical communications

Integration of AI in Medical Communications: A Roadmap

AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Using digital enhancements to maximize engagement

Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?

Best practices to implement digital enhancements and measure effectiveness...
Simplifying the omnichannel approach to publication planning

Simplifying the Omnichannel Publication Planning Approach

While the pharma and publication industries use multiple channels like emails, social media, conferences, and...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...
Image for the graphical abstracts blog by Cactus Life Sciences

Reel Your Audience in with a Visual Abstract

Graphical abstracts allow room for science communication to be reimagined in a range of creative...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
ISMPP full report image

17th Virtual Annual Meeting of ISMPP: A Summarized Report

Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...

Learn more ABOUT our company.